Just published in Resuscitation a comprehensive scoping review (of 133 studies!) to map the existing evidence on post-resuscitation care after ECPR. 👉 Read the full text here www.resuscitationjournal.com/article/S030... #ECPR #CardiacArrest #Resuscitation

Grateful for the opportunity to be invited to speak and share the stage with some of the leading experts at one of the world’s most important intensive care conferences. #ESICM #LIVES2025 @esicm.bsky.social

The European Resuscitation Council Guidelines 2025 are out now in Resuscitation! 🔗 Read the Executive Summary: www.sciencedirect.com/science/art... 🧵 Explore all the chapters in this thread #Resuscitation #RESUS25 #ERCGuidelines #Guidelines2025

Delighted to be speaking at #LIVES2025 @ESICM 38th Annual Congress in Munich. I will present on "What can we do in refractory cardiac arrest - eCPR for everyone?" I look forward to discussing advances in intensive care with a global community of clinicians and researchers.

Presented at #CCR25: In the ANH phase 3 trial involving adult patients undergoing elective cardiac surgery, acute normovolemic hemodilution did not reduce the number of patients receiving allogeneic red-cell transfusion. Full trial results: nej.md/3FxdMrW @criticalcarereviews.com

Does CPR before donor death affect organ function? We found that organs from donors who received CPR has similar outcomes to organs from donors who didn’t receive CPR. Kidneys/livers after uDCD showed worse outcomes compared to DBD. resuscitationjournal.com/article/S030...

Thank you for the visit @EduardArgudo @mariamtnezm! It was a pleasure having you in our center during #EuroELSO2025!

Very happy that #EuroELSO2025 is happening in Milano! It’s an honor to be part of this incredible event as a speaker. Looking forward to connecting, learning, and sharing insights with colleagues from all over the world. Benvenuti a Milano — and see you at EuroELSO!

PROBAST+AI is out! A risk of bias tool for prediction models developed using any kind of analytical approach (stats/ml/ai/ds) Really proud of this collaboration with many prediction model experts around the world www.bmj.com/content/388/...

The Australasian Resuscitation Outcomes Consortium (Aus-ROC) has released its Annual Report 2024. It features #OHCA in developing best practices through measuring & recording #resuscitation performance. Observations: facebook.com/ParamedProf/... Download: tinyurl.com/25ba3khr

Amazing time in Bruxelles for @ISICEM.bsky.social #ISICEM25! Until next year, #ISICEM26!

Highlights from the March 2025 Issue Discover the featured articles published in the latest issue of Resuscitation. www.resuscitationjournal.com/issue/S0300... #Resuscitation

🚨Conference Alert! Some fantastic @lancetrespirmed.bsky.social content presented today at #ISICEM25 1️⃣ Shane George with "Effectiveness of NHF oxygen during apnoea on hypoxaemia and intubation success in paediatric emergency and #ICU settings 🔗Article: tinyurl.com/5kvbk8t6 @isicem.bsky.social

#ISICEM25 | Antoni Torres on when to stop antibiotics in severe CAP 🦠💊 🔹 Outpatients: ≤5 days if stable 🔹 Non-severe inpatients: <5 days (minimum 3) 🔹 Severe CAP: ≥5 days if stable Key question: Can clinical stability criteria from CAP be applied to SCAP patients on mechanical ventilation?

Explore the latest articles on #CardiacArrest and #CPR in the March 2025 issue (Volume 208) of Resuscitation. 🔗 www.resuscitationjournal.com/issue/S0300... #Resuscitation

#ISICEM25 | Lennie Derde asks: Why is nobody using SDD despite strong evidence? 🤔💊 📊 Thousands of patients, consistent data, and mortality reduction, yet SDD remains underutilized. 🔹 Open questions: •Availability •Optimal regimen •Impact on microbiome

Guys. Isicem is on Bsky. And follow @filippodamico.bsky.social and @tscquizzato.bsky.social for isicem tweets !! 👏🏽👏🏽👏🏽👏🏽👏🏽

We are on Bluesky, follow us. #Resuscitation #ResuscitationPlus

We are on Bluesky, follow us! #Resuscitation

What’s next on ECMO? Early extubation and mobilization? Love it! Niall Ferguson #ISICEM25 @ISICEM.bsky.social

Now Luigi Camporota talking about the use of End-Tidal to Arterial PCO2 ratio as guide to weaning from VV ECMO. #ISICEM25 @ISICEM.bsky.social

Patients on ECMO experience a wide range of hemostatic disorders Julie Helms #ISICEM25 @ISICEM.bsky.social

Up next Julie Helms talking about ECMO and the role of contact phase activation in bleeding #ISICEM25 @ISICEM.bsky.social

Setting PEEP on ECMO by Matthieu Schmidt at #ISICEM25 @ISICEM.bsky.social

The plenary lecture closing Day 2 of #ISICEM25 is about to begin: Cardiogenic Shock, from Vasoactive Drugs to Mechanical Circulatory Support by @JasonKatzMD @ISICEM.bsky.social

Take home messages on neuroprognostication after cardiac arrest from #ISICEM25 @ISICEM.bsky.social

High performance of the ERC/ESICM-recommendations for neuroprognostication after cardiac arrest #ISICEM25 @ISICEM.bsky.social

Interaction between sedation, temperature and blood pressure after cardiac arrest #ISICEM25 @ISICEM.bsky.social

2nd day starts with a great session on subphenotying at #ISICEM25 Why do we bother about subphenotypes? First talk by @seymoc.bsky.social @ISICEM.bsky.social

🚨New Online and presented at #ISICEM25 today Decisions to withdraw or withhold life-sustaining therapies in patients with and without acute brain injury: a secondary analysis of cohort studies 🔗 tinyurl.com/4z6w3vv5 #criticalcare @isicem.bsky.social

Among patients with moderate to severe ARDS, inhaled sedation with sevoflurane resulted in fewer ventilator-free days at day 28 and lower 90-day survival than sedation with propofol. https://ja.ma/4kxDZGm #ISICEM25

The last talk of the opening session is about pathways to mortality in critical illness given by Schenk Edward #ISICEM25 @ISICEM.bsky.social

Up next the Max Harry Weil lecture on the past, present and future blood lactate levels by Jan Bakker #ISICEM25 @ISICEM.bsky.social

Now @pirracchior presenting the OVISS Reinforcement Learning Study: Optimal Vasopressin Initiation in Septic Shock @ISICEM.bsky.social #ISICEM25

Results of the #SESARtrial: Among patients with moderate/severe ARDS, inhaled sedation with sevoflurane resulted in - fewer ventilator-free days at day 28 - lower 90-day survival than sedation with propofol. Now published in JAMA jamanetwork.com/journals/ja... @isicem.bsky.social #ISICEM25

Up next there is @mj0b presenting for the first time the results of the #SESARtrial: Inhaled sedation in the acute respiratory distress syndrome. #ISICEM25 @isicem.bsky.social

Up next there is @shauryataran presenting on decisions to withhold or withdraw life support after acute brain injury Full article just published on @LancetRespirMed www.thelancet.com/journals/la... #ISICEM25 @ISICEM

Take-home points: The 4 R's from the roundtable conference on consciousness disorders in the ICU. #ISICEM25 @ISICEM

Why are disorder of consciousness (DoCs) relevant to the intensivist? #ISICEM25 @ISICEM @Dr_Cit

Up next @Dr_Cit and Yelena Bodien to report the results of the roundtable conference on consciousness disorders in the ICU. #ISICEM25 @isicem

#ISICEM25: @fabio_taccone is on the stage to welcome all participants. Remember, you can also watch the opening session live on Facebook: www.facebook.com/ISICEM.org @isicem.bsky.social

The #ISICEM25 congress is starting! The Gold Hall is full of excitement as people from all over the world come together. Prepare for a day filled with interesting talks and lively discussions on Intensive Care & Emergency Medicine. @ISICEM

ISICEM is more than a symposium—it’s the pulse of #IntensiveCare & #EmergencyMedicine. A place where experts connect, ideas spark, and innovation shapes the future of patient care. Be part of the movement! 🔗 isicem.org/1/Registration…#ISICEM252#TogetherAtISICEME#medicalinnovationon

@isicem.bsky.social is renowned for its full, high-quality scientific program. Watch now Prof. Fabio Taccone's recommendations & start crafting your personalized learning journey today! More sessions on isicem.org/1/ProgrammeI... #criticalcare #intensivecare #emergencymedicine

It was an honor and a pleasure to represent #UniSR last week in #Riga, during a series of meetings organized by the Italian Embassy in Latvia in collaboration with Riga Technical University, with whom #SanRaffaele has established a strong partnership.

3 brand new trials comparing IV to IO in OHCA. No survival differences. #ReSS24 #emimcc

After an excellent first day at the Resuscitation Science Symposium 2024, the second day is set to begin with a plenary session on Cardiac Arrest Due to Drugs of Abuse. #ReSS24 @ahascience.bsky.social

Late-breaking science session #ReSs24! First up the PROTECT trial examining ceftriaxone PPx after cardiac arrest @nickjohnsonmd.bsky.social @pulmtoilet.bsky.social @imcrit.bsky.social @pulmcrit.bsky.social

Next up! Looking at long term outcomes after the TTM 24 vs 48hr trial. #emimcc #ReSS24 @pulmcrit.bsky.social @tscquizzato.bsky.social @nickjohnsonmd.bsky.social @joshkimbre.bsky.social

Now on stage at the Interactive Late-Breaking Resuscitation Science Session, @MarkusSkrifvars, is presenting the results on the kong-term functional outcome and quality of life 5-8 years after the TTH48 trial #ReSS24 @ahascience.bsky.social